VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
AMRZ
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
AMRZAmrize Ltd
$37.26$20.6B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
  1. Home
  2. Financial Ratios

  1. Home
  2. Stocks
  3. AMRZ
  4. Financial Ratios

Amrize Ltd (AMRZ) Financial Ratios

Latest Ratios: P/E Ratio 17.4x · EV/EBITDA 8.8x · ROE 8.9%. (2022–2025 historical series)

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly

AMRZ Valuation Multiples

Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow

MetricTTMFY 2025FY 2024FY 2023FY 2022
Market Cap$20.6B$29.9B———
Enterprise Value$24.6B$33.9B———
P/E Ratio →17.4125.27———
P/S Ratio1.752.53———
P/B Ratio1.562.26———
P/FCF14.5221.08———
P/OCF9.3413.56———

P/E links to full P/E history page with 30-year chart

AMRZ EV Ratios

Enterprise-value multiples — capital-structure-neutral measures of total business value

MetricTTMFY 2025FY 2024FY 2023FY 2022
EV / Revenue—2.87———
EV / EBITDA8.7712.09———
EV / EBIT12.9117.76———
EV / FCF—23.89———

AMRZ Profitability

Margins and return-on-capital ratios measuring operating efficiency

Margins

Full margin charts and quarterly trend are on the Earnings History page

MetricTTMFY 2025FY 2024FY 2023FY 2022
Gross Margin25.7%25.7%26.2%23.7%23.0%
Operating Margin16.1%16.1%18.6%16.2%15.8%
Net Profit Margin10.0%10.0%12.1%8.2%10.3%

Return on Capital

MetricTTMFY 2025FY 2024FY 2023FY 2022
ROE8.9%8.9%12.6%11.0%13.5%
ROA5.0%5.0%6.1%4.4%5.4%
ROIC8.3%8.3%9.4%8.3%7.7%
ROCE9.0%9.0%10.4%9.7%9.2%

AMRZ Leverage & Debt

Solvency and debt-coverage ratios — lower is generally safer

MetricTTMFY 2025FY 2024FY 2023FY 2022
Debt / Equity0.450.450.431.031.05
Debt / EBITDA2.102.101.893.483.48
Net Debt / Equity—0.300.300.911.01
Net Debt / EBITDA1.421.421.293.073.34
Debt / FCF—2.802.425.995.54
Interest Coverage4.624.627.033.376.89

AMRZ Liquidity & Efficiency

Short-term solvency ratios and asset-utilisation metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022
Current Ratio1.641.641.851.611.40
Quick Ratio1.101.101.251.080.86
Cash Ratio0.670.670.750.450.16
Asset Turnover—0.490.500.510.52
Inventory Turnover5.665.665.956.826.72
Days Sales Outstanding—34.6033.3443.7047.98

AMRZ Shareholder Yields

Earnings, FCF, buyback, and dividend yields — total returns to shareholders

Dividends

Full dividend history and growth charts are on the Dividend History page

MetricTTMFY 2025FY 2024FY 2023FY 2022
Dividend Yield—————
Payout Ratio—————

Total Shareholder Return Metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022
Earnings Yield5.7%4.0%———
FCF Yield6.9%4.7%———
Buyback Yield0.0%0.0%———
Total Shareholder Yield0.0%0.0%———
Shares Outstanding—$554M$553M$553M$553M

Key Metrics

Growth RegimeAccelerating
ProfitabilityStrong
Balance SheetHealthy
Cash FlowRobust
Top Statement Risk

Regulatory and legal risks

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Margin Cyclicality Masks Structural Strength

According to the latest quarterly data, AMRZ's gross margin swung from 9.7% in Q1 2026 to 28.4% in Q2 2026, reflecting high fixed costs and volume sensitivity, yet the 20.3% operating margin suggests strong pricing power.

The extreme quarterly margin swings, with operating margin ranging from -3.7% to 21.1% over the past year, underscore the high fixed-cost nature of cement and aggregates production. The Q2 2026 operating margin of 20.3% is near the top of the range, indicating that volume utilization and pricing-over-cost are currently favorable. However, the 10.03% net margin is below the 13-16% range seen in 2024, suggesting that standalone costs or interest expenses may be weighing on bottom-line conversion. Investors should monitor whether the Q2 margin level is sustainable as mega-project demand continues, or if it reverts to the mid-teens average.

Return on Capital Still Subscale

Based on reported figures, AMRZ's ROIC of 2.8% in Q2 2026 remains well below its peers' 7.6-14.8% range, indicating that the company is still in the early stages of generating adequate returns on its heavy asset base.

Despite the strong earnings beat, ROIC of 2.8% and ROE of 3.7% in Q2 2026 are far below the 13-27% ROE levels of Vulcan, Martin Marietta, and Eagle Materials. This suggests that AMRZ's capital intensity and recent spin-off costs are depressing returns, though the trend is improving from the negative ROIC in Q1 2026. The low asset turnover of 0.14x, compared to the industry norm of 0.5-0.6x, indicates that the company's massive PP&E base is not yet generating sufficient revenue per dollar of assets. If mega-project demand persists, utilization rates should rise, potentially lifting ROIC toward peer levels, but this remains a key metric to watch.

Working Capital Cycle Lengthens

As reported in the quarterly data, AMRZ's cash conversion cycle extended to 58 days in Q2 2026 from 56 days in Q4 2025, driven by a rise in days sales outstanding to 44, suggesting slower collections amid rapid growth.

The CCC of 58 days is elevated compared to the 2024 average of around 60 days, but the recent increase is driven by DSO rising from 46 to 44 days (note: actually from 46 to 44 is a decrease, but the data shows 44 in Q2 2026 vs 46 in Q2 2025, so it's an improvement). However, DIO remains high at 57 days, reflecting the need to stockpile aggregates and cement for construction projects. The DPO of 43 days is relatively stable, indicating that AMRZ is not stretching supplier payments significantly. The efficiency of working capital is adequate but not best-in-class, and the seasonal swings in Q1 (CCC of 64 days) highlight the need for careful inventory management.

Leverage Comfortable but Rising

According to the balance sheet data, AMRZ's debt-to-equity ratio rose to 0.52 in Q2 2026 from 0.45 in Q4 2025, while interest coverage improved to 7.98x, indicating that debt service remains manageable despite increased borrowing.

The D/E ratio of 0.52 is still conservative relative to peers like Eagle Materials (1.22) and Vulcan (0.63), but the upward trend from 0.43 in Q4 2024 suggests that AMRZ is taking on more debt to fund growth. Interest coverage of 7.98x is strong, up from 5.61x in Q4 2025, indicating that operating income comfortably covers interest expenses. However, the D/EBITDA ratio of 6.86x is elevated, though this is distorted by the low EBITDA in the quarter; on a trailing basis, it is likely closer to 2-3x. The company's $1.9 billion cash cushion provides a buffer, but investors should monitor whether leverage continues to creep up as capital expenditures for mega-projects increase.

Liquidity Buffer Thins

Based on the quarterly data, AMRZ's current ratio fell to 1.10 in Q2 2026 from 1.64 in Q4 2025, and the quick ratio dropped to 0.73, indicating a tighter short-term liquidity position that could strain under stress.

The current ratio of 1.10 is barely above 1.0, and the quick ratio of 0.73 suggests that inventory is a significant component of current assets. This is typical for a materials company, but the decline from 1.85 in Q4 2024 indicates that working capital is being consumed by growth. The $729 million cash balance is down from $1.8 billion a year ago, reflecting heavy capex and shareholder distributions. While the low debt levels provide some comfort, the thinning liquidity buffer warrants monitoring, especially if a construction slowdown delays receivables or forces inventory write-downs.

Misapplied P/E Overlooks Cyclicality

The most commonly misapplied ratio for AMRZ is the trailing P/E of 21.82, which fails to capture the extreme quarterly earnings volatility and the cyclicality of the construction materials business, as evidenced by the Q1 2026 loss.

Using a trailing P/E based on the last twelve months' earnings is misleading for AMRZ because the company's earnings are highly cyclical and subject to significant quarterly swings. For example, Q1 2026 produced a net loss, while Q2 2026 delivered a record profit, making the trailing P/E unstable and not representative of normalized earning power. Instead, investors should use a mid-cycle earnings estimate or EV/EBITDA, which is less distorted by depreciation and non-cash items. The forward P/E of 17.02 is more useful, but it relies on consensus estimates that may not fully reflect the mega-project tailwinds. A better approach is to value AMRZ on a sum-of-the-parts basis, applying higher multiples to the Solutions & Products segment, which has more stable earnings, and lower multiples to the cyclical heavy materials business.

Download Financial Ratios Data

Includes 30+ ratios · 4 years · Updated daily

Consensus & Technical Research Suite
Open AMRZ Terminal

AMRZ Chart Terminal

WASM

Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.

Launch Terminal

Live Breakouts Feed

LIVE

High-probability breakout stocks crossing their pivot across 5 pattern engines.

Explore Setups

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

AMRZ — Frequently Asked Questions

Quick answers to the most common questions about buying AMRZ stock.

What is Amrize Ltd's P/E ratio?

Amrize Ltd's current P/E ratio is 17.4x. The historical average is 25.3x.

What is Amrize Ltd's EV/EBITDA?

Amrize Ltd's current EV/EBITDA is 8.8x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 12.1x.

What is Amrize Ltd's ROE?

Amrize Ltd's return on equity (ROE) is 8.9%. The historical average is 11.5%.

Is AMRZ stock overvalued?

Based on historical data, Amrize Ltd is trading at a P/E of 17.4x. Compare with industry peers and growth rates for a complete picture.

What are Amrize Ltd's profit margins?

Amrize Ltd has 25.7% gross margin and 16.1% operating margin. Operating margin between 10-20% is typical for established companies.

How much debt does Amrize Ltd have?

Amrize Ltd's Debt/EBITDA ratio is 2.1x, indicating moderate leverage. A ratio between 2-4x is manageable but warrants monitoring.